Drug intelligence / Profile preview

Yiqitongluo

Development stage
Unknown
Lead developer
Yunnan Provincial Hospital of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Yiqitongluo is a Traditional Chinese Medicine (TCM) hospital preparation developed by the Yunnan Provincial Hospital of Traditional Chinese Medicine, specifically indicated for the treatment of diabetic peripheral neuropathy (DPN). The formula is based on the therapeutic principle of 'replenishing Qi and dredging collaterals' to address the underlying pathology of Qi deficiency and blood stasis common in diabetic patients. It typically consists of a complex mixture of herbal ingredients, including *Astragalus membranaceus* (Huangqi), *Pueraria lobata* (Gegen), and *Salvia miltiorrhiza* (Danshen). Pharmacologically, Yiqitongluo is designed to improve peripheral microcirculation, enhance nerve conduction velocity, and provide neuroprotection by reducing oxidative stress and inhibiting the polyol pathway and the formation of advanced glycation end-products (AGEs). It is primarily administered in granule or capsule form within the hospital's clinical practice.

Brand names
Yiqitongluo
Other names
Yiqitongluo GranulesYiqitongluo CapsuleYiqitongluo Formula益气通络颗粒益气通络胶囊
02

Targets

AR (Adrenergic receptors)AGER (RAGE)

Beyond the preview

Go deeper on Yiqitongluo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yiqitongluo.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call